The role of cathelicidin LL-37 in cancer development

• Autorzy: Piktel E. , Niemirowicz K. , Wnorowska U. , Watek M. , Wollny T. , Gluszek K. , Gozdz S. , Levental I. , Bucki R.
• Języki publikacji: EN

Abstrakty

EN

Słowa kluczowe

EN

cathelicidin LL-37; antimicrobial peptide; chronic infection; carcinogenesis; cancer; immune system; biological activity

• Wydawca: -
• Czasopismo: Archivum Immunologiae et Therapiae Experimentalis
• Rocznik: 2016
• Tom: 64
• Numer: 1
• Opis fizyczny: p.33-46,fig.,ref.

Twórcy

autor

Piktel E.

• Department of Microbiological and Nanobiomedical Engineering, Medical University of Bialystok, Mickiewicza 2c, 15-222 Bialystok, Poland

autor

Niemirowicz K.

• Department of Microbiological and Nanobiomedical Engineering, Medical University of Bialystok, Mickiewicza 2c, 15-222 Bialystok, Poland

autor

Wnorowska U.

• Department of Microbiological and Nanobiomedical Engineering, Medical University of Bialystok, Mickiewicza 2c, 15-222 Bialystok, Poland

autor

Watek M.

• Holy Cross Oncology Center of Kielce, Kielce, Poland

autor

Wollny T.

• Holy Cross Oncology Center of Kielce, Kielce, Poland

autor

Gluszek K.

• Holy Cross Oncology Center of Kielce, Kielce, Poland

autor

Gozdz S.

• The Faculty of Health Sciences of The Jan Kochanowski University in Kielce, Kielce, Poland

autor

Levental I.

• Department of Integrative Biology and Pharmacology, The University of Texas Medical School, Houston, TX, USA

autor

Bucki R.

• Department of Microbiological and Nanobiomedical Engineering, Medical University of Bialystok, Mickiewicza 2c, 15-222 Bialystok, Poland
• Department of Physiology, Pathophysiology and Microbiology of Infections, Faculty of Health Sciences of The Jan Kochanowski University in Kielce, Kielce, Poland

Identyfikatory

DOI

10.1007/s00005-015-0359-5